Integra Lifesciences Holdings (IART) Profit After Tax (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Profit After Tax data on file, last reported at -$4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 81.75% year-over-year to -$4.6 million; the trailing twelve-month figure through Mar 2026 stood at -$495.8 million (down 2481.21% YoY), and the FY2025 full-year result was -$516.5 million, down 7337.7% from the prior year.
• Profit After Tax eased to -$4.6 million in Q1 2026, from -$1.7 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $55.7 million in Q3 2022 to a low of -$484.1 million in Q2 2025.
• A 5-year average of -$17.4 million and a median of $4.2 million in 2023 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax jumped 86.17% in 2023 and plunged 3803.18% in 2025, its largest moves.
• Tracing IART's Profit After Tax over 5 years: stood at $15.2 million in 2022, then jumped by 86.17% to $28.4 million in 2023, then grew by 2.92% to $29.2 million in 2024, then slumped by 105.84% to -$1.7 million in 2025, then slumped by 170.95% to -$4.6 million in 2026.
• Business Quant data shows IART's Profit After Tax at -$4.6 million in Q1 2026, -$1.7 million in Q4 2025, and -$5.4 million in Q3 2025.